Related Experiment Videos

Reactive gliosis and monoamine oxidase B

J Ekblom1, S S Jossan, L Oreland

  • 1Department of Neurology, University Hospital, Uppsala, Sweden.

Journal of Neural Transmission. Supplementum
|January 1, 1994
PubMed

Insights

Amyotrophic lateral sclerosis (ALS) involves increased monoamine oxidase B (MAO-B) in reactive astrocytes within the spinal cord. This study investigated MAO-B levels in ALS patients, revealing specific cellular changes.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
  • Monoamine oxidase B (MAO-B) is an enzyme implicated in neuroinflammation.
  • Astrocytes play a role in central nervous system homeostasis and disease.

Purpose of the Study:

  • To investigate the cellular content and distribution of monoamine oxidase B (MAO-B) in the spinal cord of ALS patients.
  • To determine if MAO-B levels differ in reactive astrocytes compared to controls.
  • To examine the expression of MAO-B in other spinal cord cell types.

Main Methods:

  • Double-staining method on human spinal cord cryosections from ALS patients and controls.
  • 3H-L-Deprenyl emulsion autoradiography combined with histochemical detection of astrocytes and monocytes/microglia.
  • Primary astrocyte cultures were used for further validation.

Main Results:

  • An increased number of astrocytes was observed in ALS spinal cords.
  • Elevated MAO-B content was found in reactive astrocytes in ALS patients.
  • No significant MAO-B binding was detected in monocytes or microglia.
  • A sub-population of reactive astrocytes with low MAO-B levels was identified.

Conclusions:

  • Reactive astrocytes in ALS spinal cords exhibit increased MAO-B.
  • MAO-B expression in reactive astrocytes may be a marker for ALS pathology.
  • Further research is needed to elucidate the specific role of MAO-B in ALS pathogenesis.

Related Concept Videos